Clinical Oncology
Volume 20, Issue 8 , Pages 582-590 , October 2008

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)

  • S. Stanley

      Affiliations

    • St James's Institute of Oncology, Leeds, UK
    • Corresponding Author InformationAuthor for correspondence: S. Stanley, Radiotherapy Department, St James's Institute of Oncology, Bexley Wing, SJUH Leeds, UK. Tel: +113-206-7600.
    • ,
  • S. Griffiths

      Affiliations

    • St James's Institute of Oncology, Leeds, UK
    • ,
  • M.R. Sydes

      Affiliations

    • MRC Clinical Trials Unit, London, UK
    • ,
  • A.R. Moore

      Affiliations

    • Royal Marsden Hospital, Fulham Road, London, UK
    • ,
  • I. Syndikus

      Affiliations

    • Clatterbridge Centre for Oncology, Wirral, UK
    • ,
  • D.P. Dearnaley

      Affiliations

    • Institute for Cancer Research and Royal Marsden Hospital, Sutton, London, UK
    • ,
  • RT01 Radiographer Trial Implementation Group on behalf of all the RT01 Collaborators

Received 5 March 2007 ,Revised 8 April 2008 ,Accepted 10 April 2008.

References 

  1. National Institute for Health and Clinical Excellence . NHS NICE Guidance on Cancer Services: Improving Outcomes in Urological Cancers – the Manual, 2002. London: National Institute for Health and Clinical Excellence; 2002;
  2. Sydes MR, Stephens RJ, Moore AR, et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol. 2004;72:199–211
  3. Dearnaley DP, Sydes MR, Langley RE, et al. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol. 2007;83(3):31–41
  4. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475–487
  5. Dearnaley DP. Radiotherapy of prostate cancer: established results and new developments. Semin Surg Oncol. 1995;11:50–59
  6. Mayles WPM, Moore AR, Aird EGA, et al. Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397). Radiother Oncol. 2004;73:199–207
  7. Moore AR, Stanley S, Bidmead AM, et al. Quality assurance of dosimetry in UK MRC RT01 trial of dose escalation using conformal radiotherapy in prostate cancer (ISRCTN 47772397). Clin Oncol. 2003;15(2):S8–S9
  8. Griffiths S, Stanley S, Sydes M RT01 Radiographers Group on behalf of all the RT01 Collaborators. Recommendations on best practice for radiographer set up of conformal radiotherapy treatment for patients with prostate cancer: experience developed during the MRC RT01 trial (ISRTCN 47772397). J Radiother Pract. 2005;4:107–117
  9. Hurkmans CW, Remeijer P, Lebesque JV, et al. Set-up verification using portal imaging: review of current clinical practice. Radiother Oncol. 2001;58:105–120
  10. Mubata CD, Bidmead AM, Ellingham LM, et al. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1998;40:221–231
  11. De Neve W, Van den Heuvel F, Coghe M, et al. Interactive use of portal imaging in pelvic irradiation. Int J Radiat Oncol Biol Phys. 1993;25:517–524
  12. Greer PB, Mortesen TM, Rad DT, et al. Comparison of two methods for anterior posterior isocenter localization in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys. 1998;41:1193–1199
  13. Bel A, Vos PH, Rodrigus PT, et al. High-precision prostate cancer irradiation by clinical application of an off-line patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys. 1996;35:321–332
  14. Dearnaley DP, Hall E, Lawrence D, et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer. 2005;92:488–498
  15. Crook JM, Raymond Y, Salhani D, et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol. 1995;37:35–42
  16. De Boer HCJ, Heijmen BJM. A protocol for the reduction of systematic patient setup errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys. 2001;50:1350–1365
  17. Denham JW, Dally MJ, Hunter K, et al. Effective decision making following a portal film: the results of a pilot study. Int J Radiat Oncol Biol Phys. 1993;26:869–876
  18. Perera T, Moseley J, Munro P. Subjectivity in interpretation of portal films. Int J Radiat Oncol Biol Phys. 1999;45(2):529–534
  19. Baumert BG, Zagralioglu O, Davis JB, et al. The use of a leg holder immobilisation device in 3D-conformal radiation therapy of prostate cancer. Radiother Oncol. 2002;65:47–52
  20. Bentel GC, Marks LB, Sherouse GW, et al. The effectiveness of immobilisation during prostate irradiation. Int J Radiat Oncol Biol Phys. 1995;31(1):143–148
  21. Bieri S, Mirabell R, Nouet P, et al. Reproducibility of conformal radiation therapy in localised carcinoma of the prostate without rigid immobilisation. Radiother Oncol. 1996;38:223–230
  22. Dawson L, Mah K, Franssen E, et al. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys. 1998;42(5):1155–1161
  23. El-Gayed AA, Bel A, Vijlbrief R, et al. Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging. Radiother Oncol. 1993;26:162–171
  24. Hanley J, Lumley MA, Mageras GS, et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 1997;37(2):435–444
  25. Rosenthal SA, Roach M, Goldsmith BJ, et al. Immobilisation improves the reproducibility of patient positioning during 6-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:921–926
  26. Soffen EM, Hanks GE, Hwang CC, Chu JCH. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilisation. Int J Radiat Oncol Biol Phys. 1991;20:141–146
  27. Song PY, Washington M, Vaida F, et al. A comparison of four patient immobilisation devices in the treatment of prostate cancer patients with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34(1):213–219
  28. Suter B, Shoulders B, MacClean M, et al. Machine verification radiographs: an opportunity for role extension. Radiography. 2000;6:245–251
  29. Academic Clinical Oncology and Radiobiology Research Network (ACORRN) . www.acorrn.org
  30. Rudat V, Scraube P, Oetzel , et al. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localised prostate cancer. Int J Radiat Oncol Biol Phys. 1996;35(5):1027–1034

PII: S0936-6555(08)00253-7

doi: 10.1016/j.clon.2008.04.019

Clinical Oncology
Volume 20, Issue 8 , Pages 582-590 , October 2008

Article Tools

* Image Usage & Resolution